News Focus
News Focus
icon url

PennyStockInvestor

06/16/14 10:10 AM

#436 RE: TapeTrades #425

ACHN insiders have recently been dumping their shares for a reason.

They obviously know that ACHN is currently grossly overvalued.

Achillion Pharmaceuticals Director Kishbauch Sells 371,937 Shares @$7.75/Share -Form 4 (Benzinga)